Teachers Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Teachers Advisors’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-182	Closed	-$63K	–	3184
2017 Q1	$63K	Hold	182	–	–	﹤0.01%	3023
2016 Q4	$64K	Hold	182	–	–	﹤0.01%	3043
2016 Q3	$73K	Hold	182	–	–	﹤0.01%	3032
2016 Q2	$108K	Buy	+182	New	+$111K	﹤0.01%	3034
2014 Q2	–	Sell	-34	Closed	-$182K	–	3188
2014 Q1	$182K	Buy	+34	New	+$161K	﹤0.01%	2913

Other funds holding EIGR

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Teachers Advisors's EIGR Position: Q2 2017 in Review

Teachers Advisors sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2017, closing a stake of 182 shares — an estimated $63K sold.

Teachers Advisors first reported a position in EIGR in Q1 2014 and held it in 5 quarters. The position peaked at $182K in Q1 2014. 39 funds tracked by Wall St. Rank hold EIGR as of Q2 2017.

Teachers Advisors reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
Teachers Advisors sold 182 Eiger BioPharmaceuticals, Inc. shares in Q2 2017, an estimated $63K.
Teachers Advisors first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
Teachers Advisors's Eiger BioPharmaceuticals, Inc. position peaked at $182K in Q1 2014.
39 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.